Abstract

Background: Precision in estimating placebo rates is important for clinical trial design.

Aim: To quantify placebo rates across relevant endpoints in Crohn’s disease [CD] trials and identify the factors influencing these rates in a contemporary meta-analysis.

Tags

Read More